Ligand ID: NTI Drugbank ID: DB00507(Nitazoxanide) Indication:For the treatment of diarrhea in adults and children caused by the protozoa Giardia lamblia, and for the treatment of diarrhea in children caused by the protozoan, Cryptosporidium parvum [FDA label]. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 3i6g | HLA, A-2 (Homosapiens) | 4 / 8 | VAL A 28TRP A 167PRO A 47TRP A 60 | 1.66A | 19.49 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 4 / 8 | VAL A 28TRP A 167PRO A 47TRP A 60 | 1.70A | 20.69 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAINS230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 4 / 8 | TRP H 47VAL H 97TRP H 117PRO L 100 | 1.74A | 21.90 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6w01 | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | VAL A 78HIS A 96PHE A 123PRO A 112 | 1.73A | 24.70 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | VAL H 181HIS H 164PHE L 116PRO H 185 | 1.73A | 18.88 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | VAL B 78HIS B 96PHE B 123PRO B 112 | 1.74A | 23.20 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | VAL A 78HIS A 96PHE A 123PRO A 112 | 1.74A | 23.20 | None | ||
![]() | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 810TRP A 800PRO A 830TRP A 598 | 1.63A | 16.41 | None MG A1005 (-4.5A)NoneNone |